Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update
August 15, 2024 08:30 ET
|
Odysight.ai Inc.
OMER, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
BioCorRx Reports Business Update for the Second Quarter of 2024
August 15, 2024 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today...
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 14, 2024 16:30 ET
|
Biofrontera Inc.
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 14, 2024 08:00 ET
|
Imunon, Inc.
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development...
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
August 14, 2024 07:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024 16:05 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024 08:05 ET
|
Palisade Bio, Inc.
– Continued progress toward commencement of Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Company continues to...
Bitech Technologies Announces Business Update and Provides Key 2024 Milestones for BESS Projects
August 12, 2024 07:30 ET
|
Bitech Technologies Corporation
Recent Solar Portfolio Divestment Provides Substantial Capital Infusion to Execute on BESS Rollout Nasdaq Uplisting On Track Newport Beach, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Bitech...
Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14
August 12, 2024 07:27 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024
August 07, 2024 17:04 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...